#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic candida Advanced systemic mastocytosis Infective uveitis Eosinophilic granulomatosis with polyangiitis Hepatitis B Antiphospholipid syndrome Barth syndrome Synovitis Infantile spasms Ichthyosis Acute lymphocytic leukaemia Small cell lung cancer extensive stage Cytomegalovirus infection Spina bifida Antiphospholipid antibodies More trials…

    Learn about Rare Diseases

    Alagille syndrome – Diagnostics Activated PI3 kinase delta syndrome Erdheim-Chester disease – Treatment Hepatic angiosarcoma – Treatment Amyotrophic lateral sclerosis – Diagnostics Fabry’s disease Nephrotic syndrome – Life with Disease Pemphigus – Treatment Sarcoidosis – Trials in Disease Marginal zone lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Natalizumab Epoetin Alfa Taminadenant Clarithromycin Emapalumab Sirexatamab Opium, Standardized Powdered Imipenem Anhydrate Prax-628 Azathioprine Belantamab Mafodotin STREPTOCOCCUS PYOGENES Oseltamivir Fluocinolone Acetonide 177Lu-Rhpsma-10.1 Pralatrexate Omo-103 Protease Baxdrostat Lithium More therapies…

    Learn about Your Condition

    Growth hormone deficiency Adenosquamous cell lung cancer Stress urinary incontinence Corneal dystrophy Oesophageal cancer metastatic Post procedural oedema Upper limb fracture Niemann-Pick disease Mechanical ventilation Progressive multiple sclerosis Radius fracture Graft versus host disease Gastric cancer recurrent Erectile dysfunction Thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Benzydamine Hydrochloride Lozenges for Non-Streptococcal Pharyngotonsillitis in Children Aged 6 to 11 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Tonsillitis
    Investigated Drugs:
    • BENZYDAMINE HYDROCHLORIDE
    Italy

  • A study to evaluate the effects of rifaximin in patients with opioid use disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Substance use disorder
    Investigated Drugs:
    • Rifaximin
    Italy

  • A study of Cesnicabtagene autoleucel compared to a drug combination for patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AUTOLOGOUS GENETICALLY MODIFIED T LYMPHOCYTES TRANSDUCED WITH LENTIVIRUS EXPRESSING CAR PROTEIN DIRECTED AGAINST BCMA
    • Elotuzumab
    • Bortezomib
    The Netherlands

  • A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial infection
    • Sepsis
    Investigated Drugs:
    • Meropenem Anhydrous
    • Sodium Chloride
    Greece

  • A study to evaluate the effect of EA-230 on the hospital stay length for patients undergoing coronary artery bypass surgery for coronary artery disease.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • (2S)-2-[[2-[[(2S)-5-AMINO-2-[[(2S)-2-AMINOPROPANOYL]AMINO]-5-OXOPENTANOYL]AMINO]ACETYL]AMINO]-3-METHYLBUTANOIC ACID
    Belgium The Netherlands

  • Evaluating ceftazidime and avibactam with rapid testing for patients with bloodstream infections, hospital-acquired pneumonia, or ventilator-associated pneumonia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Avibactam
    • Ceftazidime
    Italy
Previous Page
1 … 714 715 716 717 718 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!